ANTXR1 and neoplasm: Tumor endothelial marker 8 (TEM8), also named anthrax toxin receptor 1 (ANTXR17), is originally identified based on its over-expression in the endothelial cells (ECs) that line the tumor vasculature of human colorectal cancer8.